Reducing exposure to allergens, taking medication in case of an attack or becoming desensitised: these are the main solutions at your disposal.
Once their allergy diagnosis is made, the allergist will offer you the solution(s) most adapted to your needs to combat your allergy and to allow you to feel better.
1. Reducing exposure to allergens
Measures to evict allergens are generally the first step in the fight against the symptoms of allergy: by eliminating as far as possible contact with the allergen, the onset of symptoms is limited. In the case of allergies to house dust mites or pollen, which are virtually impossible to eradicate, these measures are not enough. Certain simple hygiene and protection measures are however useful for limiting exposure to these allergens and the risk of aggravating symptoms.
2. To alleviate attacks: symptomatic treatments
Prescribed as a first line treatment, they reduce the severity of symptoms, as and when they occur, without however “curing” the allergy.
3. Allergen immunotherapy, the only base treatment
Allergen immunotherapy is the only treatment of the “cause” of the allergy. This desensitising approach consists of gradually administering increasing doses of the allergen to which the patient is sensitised1. The aim: to restore the balance of the immune system so that it recovers a normal reaction to allergens.
- The patient tolerates increasingly larger doses of allergens,
- Inflammatory symptoms are reduced,
- Sensitivity to other allergens lessens in the long term,
- The risk of the allergy worsening into asthma diminishes2.
 Braun J.-J., et al. Recommandations pour le diagnostic et la prise en charge de la rhinite allergique (épidémiologie et physiopathologie exclues). Revue française d’allergologie 50 (2010) S3-S27
 Jacobsen L. Wahn U., Bilo B.: Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorized by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clinical and Translational Allergy 2012, 2:8